22157.jpg
2020 Next Generation Sequencing (NGS) Library Preparation Life Science Dashboard: Survey Responses from 411 Scientists Across North America and Europe
15 déc. 2020 05h43 HE | Research and Markets
Dublin, Dec. 15, 2020 (GLOBE NEWSWIRE) -- The "2020 Next Generation Sequencing (NGS) Library Preparation Life Science Dashboard Series 1 (NA & EMEA)" report has been added to...
22157.jpg
Oncology Molecular Diagnostics Markets - Global Industry Trends, Share, Size, Growth, Opportunity and Forecasts, 2014-2019 & 2020-2025
04 déc. 2020 05h58 HE | Research and Markets
Dublin, Dec. 04, 2020 (GLOBE NEWSWIRE) -- The "Oncology Molecular Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to...
22157.jpg
Global Molecular Diagnostics Market Forecast to Reach US$17.96 Billion in 2024, Growing at a CAGR of 6.16% from 2020 to 2024
10 sept. 2020 08h08 HE | Research and Markets
Dublin, Sept. 10, 2020 (GLOBE NEWSWIRE) -- The "Global Molecular Diagnostics Market (by Application, Technology, End-Use & Region): Insights & Forecast with Potential Impact of COVID-19...
LOGO-01.png
Burning Rock Reports Second Quarter 2020 Financial Results
11 août 2020 00h38 HE | Burning Rock Biotech Limited
GUANGZHOU, China, Aug. 11, 2020 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...
LOGO-01.png
Burning Rock Announces Full Exercise of Over-Allotment Option in Initial Public Offering
22 juin 2020 06h30 HE | Burning Rock Biotech Limited
GUANGZHOU, China, June 22, 2020 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (“Burning Rock” or the “Company”) (NASDAQ: BNR), a company focused on the application of next generation sequencing...
LogoPressRelease.jpg
Fluidigm and Next Gen Diagnostics Enter into Agreement to Improve the Efficiency of Pathogen Sample Preparation for Microbial Whole Genome Sequencing
03 mars 2020 08h00 HE | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif. and HINXTON, United Kingdom, March 03, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an industry leader in microfluidics technology, and Next Gen...
LOGO.jpg
Interpace Announces Extension of LabCorp Agreement
24 févr. 2020 06h55 HE | Interpace Biosciences, Inc.
 ThyGeNEXT and ThyraMIR Collaboration Extended for Another Two Years PARSIPPANY, NJ, Feb. 24, 2020 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (NASDAQ: IDXG) announced today that its...
LogoPressRelease.jpg
MOgene Selects Fluidigm Advanta Assays and Juno System to Expand Its NGS Services Portfolio
13 janv. 2020 08h30 HE | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Jan. 13, 2020 (GLOBE NEWSWIRE) -- MOgene, a leading provider of genomic and bioinformatic services in St. Louis, today announced it has selected Fluidigm’s (NASDAQ:FLDM)...
admera_health_final_logo_transparent_final.jpg
Admera Health Announces Appointment of Omar Karame as Chief Financial Officer
10 déc. 2019 11h45 HE | Admera Health, LLC
SOUTH PLAINFIELD, N.J., Dec. 10, 2019 (GLOBE NEWSWIRE) -- Admera Health, a molecular diagnostics company, welcomes Omar Karame as Chief Financial Officer to the company. Mr. Karame brings to Admera...
LogoPressRelease.jpg
Fluidigm to Participate in the 31st Annual Piper Jaffray Healthcare Conference
13 nov. 2019 16h05 HE | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Nov. 13, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...